Sitemap
October 18, 2023 Articles
Filter by Available Specialty
- 52-week data shows vitiligo improvement with povorcitinib
- Abortion information not mentioned on most health system websites
- AI model accurately predicts atrial fibrillation within 1 month of sinus rhythm
- Arthroscopic hip labral repair preferred for young patients with repairable tears
- Athletic trainer ‘shortage’ due to more opportunities, not fewer numbers
- Atopic dermatitis status does not impact molecular signature of chronic hand eczema
- Bausch + Lomb launches enVista Aspire monofocal, toric IOLs
- CAR-T may move more patients with CLL ‘toward a potential cure’
- Changes in online ranking methodology should be transparent, inform orthopedic community
- Close association of diabetes and thyroid dysfunction has clinical implications
- COVID-19 vaccination lowers risk of post-infection cardiovascular complications
- Design improvements add personal touch to TKA bearings
- Dual GLP-1/GIP agonist shows promising impact on liver fat, lipids on top of weight loss
- FDA approves Bimzelx for treatment of moderate to severe plaque psoriasis
- FDA approves Qlosi eye drop for treatment of presbyopia
- FDA approves Xphozah for the treatment of hyperphosphatemia
- FDA approves Zilbrysq to treat generalized myasthenia gravis
- Four tools that provide both asset protection and tax benefits
- Is a dual pivot bearing more effective than a medial pivot bearing in TKA?
- Medical cultures converge to form evidence-based integrative oncology program
- Migraine days, depression symptoms significantly reduced in Ajovy phase 4 study
- More men, women choosing permanent contraception after Dobbs
- Mortality burden related to heart failure with sleep apnea increasing in US
- New diagnostics, technology top agenda at Twin Cities Ocular Surface Disease Symposium
- Novel gene therapy shows preliminary efficacy for glioblastoma
- Patients who undergo surgery for meniscal tears have greater osteoarthritis progression
- Patients with well-controlled chronic urticaria may halt omalizumab treatment
- Popular fertility supplements contain ‘wide range’ of ingredients
- Pregnancy rates after intrauterine insemination higher for same-sex couples, single women
- Protection from nirsevimab may last longer than an RSV season
- Semaglutide improves HF symptoms in patients with obesity across range of preserved EF
- Skyrizi achieves outcomes of clinical, endoscopic remission in patients with Crohn’s
- Tailored diabetes education with behavioral weight management bests standard care
- Top in endocrinology: PCOS risk in kids tied to obesity; emotional distress in diabetes
- Turkish study shows 40% lower mortality for patients on HHD vs. in-center dialysis
- Twice-daily evobrutinib linked to lower relapse, less clinical worsening after 5 years
- VIDEO: Academic orthopedic departments share challenges, solutions
- VIDEO: Digital visualization tools offer enhanced view during surgery
- VIDEO: IDSA’s new president sets some goals
- VIDEO: Tremfya maintains clinical, endoscopic efficacy through 3 years in Crohn’s disease
- VIDEO: Updated, evidence-based PCOS guidelines explained
- VIDEO: Where Dobbs affects fertility care
- Vision satisfaction at dispensing visit may predict multifocal contact lens success
- Women less likely to be diagnosed with, offered treatment for OSA
- Women nearly 50% likelier to develop depression after TBI compared with men, study finds
- Young woman with proximal tibia fracture, nonunion after tibial tubercle osteotomy